ZYNERBA PHARMACEUTICALS, INC.: accounts_payable
| Value | {"amount": 3355255, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2017-12-31) |
| Status | current |
| Entity | ZYNERBA PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T16:40:57.256000+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/6bb5a366-c8f4-468f-b30e-53fec460912c
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001558370-18-001906 · Open the official SEC filing →Retrieved: 2026-08-19T16:40:57.256000+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001621443/accounts-payable/2017-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/6bb5a366-c8f4-468f-b30e-53fec460912c
History
- no predecessors — first report